Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Modified Citrus Pectin (MCP) is a dietary supplement made by breaking down pectin, a natural fiber found in the peels and pulp of citrus fruits such as oranges, lemons, and grapefruits. Normally, pectin molecules are too large to be absorbed by the digestive system. MCP is processed into smaller pieces that can enter the bloodstream after being taken by mouth. This supplement is often discussed because it may interact with a protein in the body called galectin-3.
Galectin-3 is a protein involved in many body processes, including cell communication, inflammation, tissue repair, and scar formation. In cancer, galectin-3 may help tumor cells survive, stick to other cells, spread to new areas, and avoid the immune system. Because of this, scientists are exploring whether blocking galectin-3 could slow cancer growth or spread. MCP is thought to bind to galectin-3 and reduce its activity, a process called galectin-3 inhibition. Laboratory and animal studies have shown some promising effects, but strong evidence from human clinical trials is still lacking.
Patients may hear about MCP as a natural supplement that could help reduce cancer spread or support the immune system. It might be mentioned in integrative oncology programs or alternative health discussions. Some people use MCP hoping to improve energy, appetite, or quality of life, especially when standard treatments cause side effects. Experiences vary widely—some report benefits, while others notice no change or mild digestive side effects like gas or bloating. MCP products differ in formulation and dose, so it is important to use them carefully and under medical supervision.
Seeing the term Modified Citrus Pectin or galectin-3 inhibition does not mean MCP is a proven cancer cure or that it replaces standard treatments like surgery, chemotherapy, or radiation. It also does not guarantee symptom relief or improved survival. Laboratory findings do not always translate into real benefits for patients. MCP use should not delay or interfere with effective cancer therapies. It is considered experimental and supportive rather than a primary cancer treatment.
MCP is generally considered safe with mild side effects such as digestive discomfort, gas, or loose stools. However, product quality and composition can vary among manufacturers. Supplements can interact with medications or medical conditions, so it is important to discuss MCP use with your healthcare team. This is especially important if you are receiving cancer treatments, have other health issues, or take multiple medications. Your care team can help you understand if MCP is appropriate and safe for your situation.
If you are interested in MCP, talk openly with your oncology team before starting it. They can help you weigh potential benefits and risks, avoid interactions with your cancer treatments, and ensure MCP use fits your overall care plan. Remember that MCP is not an approved cancer treatment but may be part of supportive care or complementary approaches. Staying informed and working closely with your healthcare providers is the best way to make safe and effective choices during cancer care.
Public source information used for this glossary entry includes: